Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Remdesivir, Veklury, drugs, syringe.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Velkury, drugs, sign, box

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Remdesivir, Veklury, drugs, syringe, hands in gloves.

Experimental antiviral drug for COVID-19 Remdesivir, in Prague, Czech Republic, April 5, 2021. (CTK Photo/Martin Macak Gregor)

E

Medicine Remdesivir, hospitalised coronavirus patients, doctors, General University Hospital in Prague

Czechia sees highest daily rise in hospitalised COVID-19 patients. On Tuesday, 976 people were in Czech hospitals, including more than 200 in serious condition. The rise in people with COVID-19 treated in hospital was 151 on Tuesday, which has been the highest daily number of hospitalised infected persons since the epidemic outbreak in March. Hospitalised coronavirus patients in General University Hospital in Prague, Czech Republic, September 30, 2020. (CTK Photo/Ondrej Deml)

E

Medicine Remdesivir, hospitalised coronavirus patients, doctors, General University Hospital in Prague

Czechia sees highest daily rise in hospitalised COVID-19 patients. On Tuesday, 976 people were in Czech hospitals, including more than 200 in serious condition. The rise in people with COVID-19 treated in hospital was 151 on Tuesday, which has been the highest daily number of hospitalised infected persons since the epidemic outbreak in March. Hospitalised coronavirus patients in General University Hospital in Prague, Czech Republic, September 30, 2020. (CTK Photo/Ondrej Deml)

E

Robert Markovic, Martin Balik

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (left), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. On the right side is seen doctor Martin Balik. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic, David Feltl

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (left), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. On the right side is seen director of the hospital David Feltl. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic, Michal Sotola

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (left), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. On the right side is seen doctor Michal Sotola. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Robert Markovic

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (photo), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik

Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

David Feltl

Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

David Feltl

Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 24, 2020, in Prague, Czech Republic. The hospital received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19. (CTK Photo/Ondrej Deml)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 24, 2020, in Prague, Czech Republic. The hospital received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19. (CTK Photo/Ondrej Deml)

E

Martin Balik

Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 24, 2020, in Prague, Czech Republic. The hospital received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19. (CTK Photo/Ondrej Deml)

E

New coronavirus

Japanese health minister Katsunobu Kato (C) meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo

E

New coronavirus

Japanese health minister Katsunobu Kato meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo

E

New coronavirus

Japanese health minister Katsunobu Kato meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo

E

New coronavirus

Japanese health minister Katsunobu Kato meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo

E

New coronavirus

Japanese health minister Katsunobu Kato meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo

E

New coronavirus

Japanese health minister Katsunobu Kato meets the press in Tokyo on May 7, 2020, after the government approved the use of the anti-viral drug Remdesivir for new coronavirus patients. (Kyodo) ==Kyodo